Study of Relationship Between Changes in Inflammation, Lung Function, Symptoms and Medication Use in COPD Patients

Trial Identifier: D6930R00002
Sponsor: AstraZeneca
Collaborator:
UNIVERSITY OF OXFORD
NCTID:: NCT04168216
Start Date: November 2020
Primary Completion Date: June 2022
Study Completion Date: June 2022
Condition: Chronic Obstructive Pulmonary Disease (COPD)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
United Kingdom, Oxfordshire Oxford, Oxfordshire, United Kingdom, OX3 7LE